FdaApplication
ANDA 210323
Identifiers
- fda_app_no: ANDA210323
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
| approval_date | 2018-04-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EXEMESTANE | EXEMESTANE | 25MG | TABLET;ORAL |
1 product